<tablegroup Reference="id68-----39-----BCMA;17-001511;-20C;INVERTED" id="id68-----39-----BCMA;17-001511;-20C;INVERTED">
  <h3 tableHeader="yes">0.0.0.0.0-3. Drug Product Stability Long-Term Batch 17-001511 for -20C</h3>
  <table border="1" pagebreak="true" width="100%" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1" parent_tablegroup="id68-----39-----BCMA;17-001511;-20C;INVERTED" class="output-table" seq="1">
    <tr>
      <th rowSpan="2" columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Appearance___Appearance___Appearance___Biological Activity (Binding ELISA)___CEX-HPLC___CEX-HPLC-----Time (Months)___Time (Months)-----Time (Months)">Time (Months)</th>
      <th colSpan="3" columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Appearance___Appearance___Appearance___Biological Activity (Binding ELISA)___CEX-HPLC___CEX-HPLC-----APPEARANCE___CLARITY-----Appearance">Appearance</th>
      <th columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Appearance___Appearance___Appearance___Biological Activity (Binding ELISA)___CEX-HPLC___CEX-HPLC-----BIOLOGICAL ACTIVITY (BINDING ELISA)___RELATIVE POTENCY-----Biological Activity (Binding ELISA)">Biological Activity (Binding ELISA)</th>
      <th colSpan="2" columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Appearance___Appearance___Appearance___Biological Activity (Binding ELISA)___CEX-HPLC___CEX-HPLC-----CEX-HPLC___ANTI-BCMA MAB-----CEX-HPLC">CEX-HPLC</th>
      <th colSpan="3" columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Appearance___Appearance___Appearance___Biological Activity (Binding ELISA)___CEX-HPLC___CEX-HPLC-----CGE (NON-REDUCING)___FRAGMENTS-----CGE (non-reducing)">CGE (non-reducing)</th>
      <th colSpan="3" columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Appearance___Appearance___Appearance___Biological Activity (Binding ELISA)___CEX-HPLC___CEX-HPLC-----CGE (REDUCING)___FRAGMENTS-----CGE (reducing)">CGE (reducing)</th>
      <th rowSpan="2" columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Appearance___Appearance___Appearance___Biological Activity (Binding ELISA)___CEX-HPLC___CEX-HPLC-----ENDOTOXIN___ENDOTOXIN-----Endotoxin">Endotoxin</th>
      <th rowSpan="2" columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Appearance___Appearance___Appearance___Biological Activity (Binding ELISA)___CEX-HPLC___CEX-HPLC-----OSMOLARITY___OSMOLARITY-----Osmolarity">Osmolarity</th>
      <th columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Appearance___Appearance___Appearance___Biological Activity (Binding ELISA)___CEX-HPLC___CEX-HPLC-----PEPTIDE MAPPING___IDENTITY (PEPTIDE PROFILE)-----Peptide Mapping">Peptide Mapping</th>
      <th colSpan="2" columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Appearance___Appearance___Appearance___Biological Activity (Binding ELISA)___CEX-HPLC___CEX-HPLC-----SE-HPLC___HMMS-----SE-HPLC">SE-HPLC</th>
      <th rowSpan="2" columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Appearance___Appearance___Appearance___Biological Activity (Binding ELISA)___CEX-HPLC___CEX-HPLC-----STERILITY___STERILITY-----Sterility">Sterility</th>
      <th rowSpan="2" columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Appearance___Appearance___Appearance___Biological Activity (Binding ELISA)___CEX-HPLC___CEX-HPLC-----SUBVISIBLE PARTICLES___SUBVISIBLE PARTICLES-----Subvisible Particles">Subvisible Particles</th>
      <th colSpan="2" columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Appearance___Appearance___Appearance___Biological Activity (Binding ELISA)___CEX-HPLC___CEX-HPLC-----SUBVISIBLE PARTICLES___SUBVISIBLE PARTICLES &gt;= 10M-----Subvisible Particles">Subvisible Particles</th>
      <th columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Appearance___Appearance___Appearance___Biological Activity (Binding ELISA)___CEX-HPLC___CEX-HPLC-----UV SPECTROSCOPY___PROTEIN CONCENTRATION-----UV Spectroscopy">UV Spectroscopy</th>
      <th colSpan="3" columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Appearance___Appearance___Appearance___Biological Activity (Binding ELISA)___CEX-HPLC___CEX-HPLC-----ICE___ACIDIC SPECIES-----iCE">iCE</th>
      <th rowSpan="2" columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Appearance___Appearance___Appearance___Biological Activity (Binding ELISA)___CEX-HPLC___CEX-HPLC-----PH___PH-----pH">pH</th>
    </tr>
    <tr>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Clarity___Coloration___Visible Particulates___Relative Potency___Anti-BCMA mAb___Anti-BCMA/Anti-CD3 Bispecific Clip-----APPEARANCE___CLARITY-----Clarity">Clarity</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Clarity___Coloration___Visible Particulates___Relative Potency___Anti-BCMA mAb___Anti-BCMA/Anti-CD3 Bispecific Clip-----APPEARANCE___COLORATION-----Coloration">Coloration</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Clarity___Coloration___Visible Particulates___Relative Potency___Anti-BCMA mAb___Anti-BCMA/Anti-CD3 Bispecific Clip-----APPEARANCE___VISIBLE PARTICULATES-----Visible Particulates">Visible Particulates</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Clarity___Coloration___Visible Particulates___Relative Potency___Anti-BCMA mAb___Anti-BCMA/Anti-CD3 Bispecific Clip-----BIOLOGICAL ACTIVITY (BINDING ELISA)___RELATIVE POTENCY-----Relative Potency">Relative Potency</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Clarity___Coloration___Visible Particulates___Relative Potency___Anti-BCMA mAb___Anti-BCMA/Anti-CD3 Bispecific Clip-----CEX-HPLC___ANTI-BCMA MAB-----Anti-BCMA mAb">Anti-BCMA mAb</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Clarity___Coloration___Visible Particulates___Relative Potency___Anti-BCMA mAb___Anti-BCMA/Anti-CD3 Bispecific Clip-----CEX-HPLC___ANTI-BCMA/ANTI-CD3 BISPECIFIC CLIP-----Anti-BCMA/Anti-CD3 Bispecific Clip">Anti-BCMA/Anti-CD3 Bispecific Clip</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Clarity___Coloration___Visible Particulates___Relative Potency___Anti-BCMA mAb___Anti-BCMA/Anti-CD3 Bispecific Clip-----CGE (NON-REDUCING)___FRAGMENTS-----Fragments">Fragments</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Clarity___Coloration___Visible Particulates___Relative Potency___Anti-BCMA mAb___Anti-BCMA/Anti-CD3 Bispecific Clip-----CGE (NON-REDUCING)___INTACT IGG-----Intact IgG">Intact IgG</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Clarity___Coloration___Visible Particulates___Relative Potency___Anti-BCMA mAb___Anti-BCMA/Anti-CD3 Bispecific Clip-----CGE (NON-REDUCING)___OTHER-----Other">Other</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Clarity___Coloration___Visible Particulates___Relative Potency___Anti-BCMA mAb___Anti-BCMA/Anti-CD3 Bispecific Clip-----CGE (REDUCING)___FRAGMENTS-----Fragments">Fragments</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Clarity___Coloration___Visible Particulates___Relative Potency___Anti-BCMA mAb___Anti-BCMA/Anti-CD3 Bispecific Clip-----CGE (REDUCING)___HEAVY CHAIN + LIGHT CHAIN-----Heavy Chain + Light Chain">Heavy Chain + Light Chain</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Clarity___Coloration___Visible Particulates___Relative Potency___Anti-BCMA mAb___Anti-BCMA/Anti-CD3 Bispecific Clip-----CGE (REDUCING)___OTHER-----Other">Other</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Clarity___Coloration___Visible Particulates___Relative Potency___Anti-BCMA mAb___Anti-BCMA/Anti-CD3 Bispecific Clip-----PEPTIDE MAPPING___IDENTITY (PEPTIDE PROFILE)-----Identity (Peptide Profile)">Identity (Peptide Profile)</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Clarity___Coloration___Visible Particulates___Relative Potency___Anti-BCMA mAb___Anti-BCMA/Anti-CD3 Bispecific Clip-----SE-HPLC___HMMS-----HMMS">HMMS</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Clarity___Coloration___Visible Particulates___Relative Potency___Anti-BCMA mAb___Anti-BCMA/Anti-CD3 Bispecific Clip-----SE-HPLC___MONOMER-----Monomer">Monomer</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Clarity___Coloration___Visible Particulates___Relative Potency___Anti-BCMA mAb___Anti-BCMA/Anti-CD3 Bispecific Clip-----SUBVISIBLE PARTICLES___SUBVISIBLE PARTICLES &gt;= 10M-----Subvisible Particles &gt;= 10Âµm">Subvisible Particles &gt;= 10Âµm</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Clarity___Coloration___Visible Particulates___Relative Potency___Anti-BCMA mAb___Anti-BCMA/Anti-CD3 Bispecific Clip-----SUBVISIBLE PARTICLES___SUBVISIBLE PARTICLES &gt;= 25M-----Subvisible Particles &gt;= 25Âµm">Subvisible Particles &gt;= 25Âµm</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Clarity___Coloration___Visible Particulates___Relative Potency___Anti-BCMA mAb___Anti-BCMA/Anti-CD3 Bispecific Clip-----UV SPECTROSCOPY___PROTEIN CONCENTRATION-----Protein Concentration">Protein Concentration</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Clarity___Coloration___Visible Particulates___Relative Potency___Anti-BCMA mAb___Anti-BCMA/Anti-CD3 Bispecific Clip-----ICE___ACIDIC SPECIES-----Acidic Species">Acidic Species</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Clarity___Coloration___Visible Particulates___Relative Potency___Anti-BCMA mAb___Anti-BCMA/Anti-CD3 Bispecific Clip-----ICE___BASIC SPECIES-----Basic Species">Basic Species</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Time (Months)___Clarity___Coloration___Visible Particulates___Relative Potency___Anti-BCMA mAb___Anti-BCMA/Anti-CD3 Bispecific Clip-----ICE___MAIN SPECIES-----Main Species">Main Species</th>
    </tr>
    <tr>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria___&lt;= 18 NTU___Not more intensely colored than level 5 of the color standard___Essentially free from visible particulates___50 - 150% potency relative to reference material___&lt;= 3.0% anti BCMA parent mAb___&lt;= 5.0% Bispecific mAb Clip-----Time (Months)___Time (Months)">Clinical Acceptance Criteria</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria___&lt;= 18 NTU___Not more intensely colored than level 5 of the color standard___Essentially free from visible particulates___50 - 150% potency relative to reference material___&lt;= 3.0% anti BCMA parent mAb___&lt;= 5.0% Bispecific mAb Clip-----APPEARANCE___CLARITY">&lt;= 18 NTU</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria___&lt;= 18 NTU___Not more intensely colored than level 5 of the color standard___Essentially free from visible particulates___50 - 150% potency relative to reference material___&lt;= 3.0% anti BCMA parent mAb___&lt;= 5.0% Bispecific mAb Clip-----APPEARANCE___COLORATION">Not more intensely colored than level 5 of the color standard</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria___&lt;= 18 NTU___Not more intensely colored than level 5 of the color standard___Essentially free from visible particulates___50 - 150% potency relative to reference material___&lt;= 3.0% anti BCMA parent mAb___&lt;= 5.0% Bispecific mAb Clip-----APPEARANCE___VISIBLE PARTICULATES">Essentially free from visible particulates</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria___&lt;= 18 NTU___Not more intensely colored than level 5 of the color standard___Essentially free from visible particulates___50 - 150% potency relative to reference material___&lt;= 3.0% anti BCMA parent mAb___&lt;= 5.0% Bispecific mAb Clip-----BIOLOGICAL ACTIVITY (BINDING ELISA)___RELATIVE POTENCY">50 - 150% potency relative to reference material</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria___&lt;= 18 NTU___Not more intensely colored than level 5 of the color standard___Essentially free from visible particulates___50 - 150% potency relative to reference material___&lt;= 3.0% anti BCMA parent mAb___&lt;= 5.0% Bispecific mAb Clip-----CEX-HPLC___ANTI-BCMA MAB">&lt;= 3.0% anti BCMA parent mAb</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria___&lt;= 18 NTU___Not more intensely colored than level 5 of the color standard___Essentially free from visible particulates___50 - 150% potency relative to reference material___&lt;= 3.0% anti BCMA parent mAb___&lt;= 5.0% Bispecific mAb Clip-----CEX-HPLC___ANTI-BCMA/ANTI-CD3 BISPECIFIC CLIP">&lt;= 5.0% Bispecific mAb Clip</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria___&lt;= 18 NTU___Not more intensely colored than level 5 of the color standard___Essentially free from visible particulates___50 - 150% potency relative to reference material___&lt;= 3.0% anti BCMA parent mAb___&lt;= 5.0% Bispecific mAb Clip-----CGE (NON-REDUCING)___FRAGMENTS">&lt;= 10.0% fragments</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria___&lt;= 18 NTU___Not more intensely colored than level 5 of the color standard___Essentially free from visible particulates___50 - 150% potency relative to reference material___&lt;= 3.0% anti BCMA parent mAb___&lt;= 5.0% Bispecific mAb Clip-----CGE (NON-REDUCING)___INTACT IGG">&gt;= 90.0% IgG</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria___&lt;= 18 NTU___Not more intensely colored than level 5 of the color standard___Essentially free from visible particulates___50 - 150% potency relative to reference material___&lt;= 3.0% anti BCMA parent mAb___&lt;= 5.0% Bispecific mAb Clip-----CGE (NON-REDUCING)___OTHER">Report Results</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria___&lt;= 18 NTU___Not more intensely colored than level 5 of the color standard___Essentially free from visible particulates___50 - 150% potency relative to reference material___&lt;= 3.0% anti BCMA parent mAb___&lt;= 5.0% Bispecific mAb Clip-----CGE (REDUCING)___FRAGMENTS">-</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria___&lt;= 18 NTU___Not more intensely colored than level 5 of the color standard___Essentially free from visible particulates___50 - 150% potency relative to reference material___&lt;= 3.0% anti BCMA parent mAb___&lt;= 5.0% Bispecific mAb Clip-----CGE (REDUCING)___HEAVY CHAIN + LIGHT CHAIN">-</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria___&lt;= 18 NTU___Not more intensely colored than level 5 of the color standard___Essentially free from visible particulates___50 - 150% potency relative to reference material___&lt;= 3.0% anti BCMA parent mAb___&lt;= 5.0% Bispecific mAb Clip-----CGE (REDUCING)___OTHER">-</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria___&lt;= 18 NTU___Not more intensely colored than level 5 of the color standard___Essentially free from visible particulates___50 - 150% potency relative to reference material___&lt;= 3.0% anti BCMA parent mAb___&lt;= 5.0% Bispecific mAb Clip-----ENDOTOXIN___ENDOTOXIN">&lt;= 10 EU/mg</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria___&lt;= 18 NTU___Not more intensely colored than level 5 of the color standard___Essentially free from visible particulates___50 - 150% potency relative to reference material___&lt;= 3.0% anti BCMA parent mAb___&lt;= 5.0% Bispecific mAb Clip-----OSMOLARITY___OSMOLARITY">Report Results</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria___&lt;= 18 NTU___Not more intensely colored than level 5 of the color standard___Essentially free from visible particulates___50 - 150% potency relative to reference material___&lt;= 3.0% anti BCMA parent mAb___&lt;= 5.0% Bispecific mAb Clip-----PEPTIDE MAPPING___IDENTITY (PEPTIDE PROFILE)">Comparable to Reference</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria___&lt;= 18 NTU___Not more intensely colored than level 5 of the color standard___Essentially free from visible particulates___50 - 150% potency relative to reference material___&lt;= 3.0% anti BCMA parent mAb___&lt;= 5.0% Bispecific mAb Clip-----SE-HPLC___HMMS">&lt;= 5.0% HMMS</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria___&lt;= 18 NTU___Not more intensely colored than level 5 of the color standard___Essentially free from visible particulates___50 - 150% potency relative to reference material___&lt;= 3.0% anti BCMA parent mAb___&lt;= 5.0% Bispecific mAb Clip-----SE-HPLC___MONOMER">&gt;= 90.0% monomer</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria___&lt;= 18 NTU___Not more intensely colored than level 5 of the color standard___Essentially free from visible particulates___50 - 150% potency relative to reference material___&lt;= 3.0% anti BCMA parent mAb___&lt;= 5.0% Bispecific mAb Clip-----STERILITY___STERILITY">No growth detected</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria___&lt;= 18 NTU___Not more intensely colored than level 5 of the color standard___Essentially free from visible particulates___50 - 150% potency relative to reference material___&lt;= 3.0% anti BCMA parent mAb___&lt;= 5.0% Bispecific mAb Clip-----SUBVISIBLE PARTICLES___SUBVISIBLE PARTICLES">Meets compendial requirements</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria___&lt;= 18 NTU___Not more intensely colored than level 5 of the color standard___Essentially free from visible particulates___50 - 150% potency relative to reference material___&lt;= 3.0% anti BCMA parent mAb___&lt;= 5.0% Bispecific mAb Clip-----SUBVISIBLE PARTICLES___SUBVISIBLE PARTICLES &gt;= 10M">Report Results</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria___&lt;= 18 NTU___Not more intensely colored than level 5 of the color standard___Essentially free from visible particulates___50 - 150% potency relative to reference material___&lt;= 3.0% anti BCMA parent mAb___&lt;= 5.0% Bispecific mAb Clip-----SUBVISIBLE PARTICLES___SUBVISIBLE PARTICLES &gt;= 25M">Report Results</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria___&lt;= 18 NTU___Not more intensely colored than level 5 of the color standard___Essentially free from visible particulates___50 - 150% potency relative to reference material___&lt;= 3.0% anti BCMA parent mAb___&lt;= 5.0% Bispecific mAb Clip-----UV SPECTROSCOPY___PROTEIN CONCENTRATION">2.0 +/- 0.2 mg/mL</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria___&lt;= 18 NTU___Not more intensely colored than level 5 of the color standard___Essentially free from visible particulates___50 - 150% potency relative to reference material___&lt;= 3.0% anti BCMA parent mAb___&lt;= 5.0% Bispecific mAb Clip-----ICE___ACIDIC SPECIES">Report Results</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria___&lt;= 18 NTU___Not more intensely colored than level 5 of the color standard___Essentially free from visible particulates___50 - 150% potency relative to reference material___&lt;= 3.0% anti BCMA parent mAb___&lt;= 5.0% Bispecific mAb Clip-----ICE___BASIC SPECIES">Report Results</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria___&lt;= 18 NTU___Not more intensely colored than level 5 of the color standard___Essentially free from visible particulates___50 - 150% potency relative to reference material___&lt;= 3.0% anti BCMA parent mAb___&lt;= 5.0% Bispecific mAb Clip-----ICE___MAIN SPECIES">Report Results</th>
      <th id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----Clinical Acceptance Criteria___&lt;= 18 NTU___Not more intensely colored than level 5 of the color standard___Essentially free from visible particulates___50 - 150% potency relative to reference material___&lt;= 3.0% anti BCMA parent mAb___&lt;= 5.0% Bispecific mAb Clip-----PH___PH">5.8 +/- 0.5</th>
    </tr>
    <tr>
      <td columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0___1___&lt;=B9___Essentially free from visible particulates___92___NMT 0.1___0.4-----Time (Months)___Time (Months)">0</td>
      <td columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0___1___&lt;=B9___Essentially free from visible particulates___92___NMT 0.1___0.4-----APPEARANCE___CLARITY">1</td>
      <td columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0___1___&lt;=B9___Essentially free from visible particulates___92___NMT 0.1___0.4-----APPEARANCE___COLORATION">&lt;=B9</td>
      <td columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0___1___&lt;=B9___Essentially free from visible particulates___92___NMT 0.1___0.4-----APPEARANCE___VISIBLE PARTICULATES">Essentially free from visible particulates</td>
      <td columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0___1___&lt;=B9___Essentially free from visible particulates___92___NMT 0.1___0.4-----BIOLOGICAL ACTIVITY (BINDING ELISA)___RELATIVE POTENCY">92</td>
      <td columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0___1___&lt;=B9___Essentially free from visible particulates___92___NMT 0.1___0.4-----CEX-HPLC___ANTI-BCMA MAB">NMT 0.1</td>
      <td columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0___1___&lt;=B9___Essentially free from visible particulates___92___NMT 0.1___0.4-----CEX-HPLC___ANTI-BCMA/ANTI-CD3 BISPECIFIC CLIP">0.4</td>
      <td columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0___1___&lt;=B9___Essentially free from visible particulates___92___NMT 0.1___0.4-----CGE (NON-REDUCING)___FRAGMENTS">0.8</td>
      <td columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0___1___&lt;=B9___Essentially free from visible particulates___92___NMT 0.1___0.4-----CGE (NON-REDUCING)___INTACT IGG">99.2</td>
      <td columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0___1___&lt;=B9___Essentially free from visible particulates___92___NMT 0.1___0.4-----CGE (NON-REDUCING)___OTHER">NMT 0.3</td>
      <td columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0___1___&lt;=B9___Essentially free from visible particulates___92___NMT 0.1___0.4-----CGE (REDUCING)___FRAGMENTS">0.9</td>
      <td columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0___1___&lt;=B9___Essentially free from visible particulates___92___NMT 0.1___0.4-----CGE (REDUCING)___HEAVY CHAIN + LIGHT CHAIN">99.1</td>
      <td columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0___1___&lt;=B9___Essentially free from visible particulates___92___NMT 0.1___0.4-----CGE (REDUCING)___OTHER">NMT 0.3</td>
      <td columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0___1___&lt;=B9___Essentially free from visible particulates___92___NMT 0.1___0.4-----ENDOTOXIN___ENDOTOXIN">NMT 1</td>
      <td columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0___1___&lt;=B9___Essentially free from visible particulates___92___NMT 0.1___0.4-----OSMOLARITY___OSMOLARITY">310</td>
      <td columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0___1___&lt;=B9___Essentially free from visible particulates___92___NMT 0.1___0.4-----PEPTIDE MAPPING___IDENTITY (PEPTIDE PROFILE)">Comparable to Reference</td>
      <td columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0___1___&lt;=B9___Essentially free from visible particulates___92___NMT 0.1___0.4-----SE-HPLC___HMMS">0.4</td>
      <td columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0___1___&lt;=B9___Essentially free from visible particulates___92___NMT 0.1___0.4-----SE-HPLC___MONOMER">99.6</td>
      <td columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0___1___&lt;=B9___Essentially free from visible particulates___92___NMT 0.1___0.4-----STERILITY___STERILITY">No growth detected</td>
      <td columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0___1___&lt;=B9___Essentially free from visible particulates___92___NMT 0.1___0.4-----SUBVISIBLE PARTICLES___SUBVISIBLE PARTICLES">Meets compendial requirements</td>
      <td columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0___1___&lt;=B9___Essentially free from visible particulates___92___NMT 0.1___0.4-----SUBVISIBLE PARTICLES___SUBVISIBLE PARTICLES &gt;= 10M">5</td>
      <td columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0___1___&lt;=B9___Essentially free from visible particulates___92___NMT 0.1___0.4-----SUBVISIBLE PARTICLES___SUBVISIBLE PARTICLES &gt;= 25M">&lt;1</td>
      <td columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0___1___&lt;=B9___Essentially free from visible particulates___92___NMT 0.1___0.4-----UV SPECTROSCOPY___PROTEIN CONCENTRATION">2.0</td>
      <td columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0___1___&lt;=B9___Essentially free from visible particulates___92___NMT 0.1___0.4-----ICE___ACIDIC SPECIES">38.7</td>
      <td columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0___1___&lt;=B9___Essentially free from visible particulates___92___NMT 0.1___0.4-----ICE___BASIC SPECIES">14.7</td>
      <td columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0___1___&lt;=B9___Essentially free from visible particulates___92___NMT 0.1___0.4-----ICE___MAIN SPECIES">46.6</td>
      <td columnWidth="10" id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----0___1___&lt;=B9___Essentially free from visible particulates___92___NMT 0.1___0.4-----PH___PH">5.7</td>
    </tr>
    <tr>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1___2___&lt;=B9___Essentially free from visible particulates___97___0.2___0.6-----Time (Months)___Time (Months)">1</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1___2___&lt;=B9___Essentially free from visible particulates___97___0.2___0.6-----APPEARANCE___CLARITY">2</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1___2___&lt;=B9___Essentially free from visible particulates___97___0.2___0.6-----APPEARANCE___COLORATION">&lt;=B9</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1___2___&lt;=B9___Essentially free from visible particulates___97___0.2___0.6-----APPEARANCE___VISIBLE PARTICULATES">Essentially free from visible particulates</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1___2___&lt;=B9___Essentially free from visible particulates___97___0.2___0.6-----BIOLOGICAL ACTIVITY (BINDING ELISA)___RELATIVE POTENCY">97</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1___2___&lt;=B9___Essentially free from visible particulates___97___0.2___0.6-----CEX-HPLC___ANTI-BCMA MAB">0.2</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1___2___&lt;=B9___Essentially free from visible particulates___97___0.2___0.6-----CEX-HPLC___ANTI-BCMA/ANTI-CD3 BISPECIFIC CLIP">0.6</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1___2___&lt;=B9___Essentially free from visible particulates___97___0.2___0.6-----CGE (NON-REDUCING)___FRAGMENTS">0.5</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1___2___&lt;=B9___Essentially free from visible particulates___97___0.2___0.6-----CGE (NON-REDUCING)___INTACT IGG">99.5</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1___2___&lt;=B9___Essentially free from visible particulates___97___0.2___0.6-----CGE (NON-REDUCING)___OTHER">NMT 0.3</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1___2___&lt;=B9___Essentially free from visible particulates___97___0.2___0.6-----CGE (REDUCING)___FRAGMENTS">0.9</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1___2___&lt;=B9___Essentially free from visible particulates___97___0.2___0.6-----CGE (REDUCING)___HEAVY CHAIN + LIGHT CHAIN">99.1</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1___2___&lt;=B9___Essentially free from visible particulates___97___0.2___0.6-----CGE (REDUCING)___OTHER">NMT 0.3</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1___2___&lt;=B9___Essentially free from visible particulates___97___0.2___0.6-----ENDOTOXIN___ENDOTOXIN">NR</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1___2___&lt;=B9___Essentially free from visible particulates___97___0.2___0.6-----OSMOLARITY___OSMOLARITY">NR</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1___2___&lt;=B9___Essentially free from visible particulates___97___0.2___0.6-----PEPTIDE MAPPING___IDENTITY (PEPTIDE PROFILE)">NR</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1___2___&lt;=B9___Essentially free from visible particulates___97___0.2___0.6-----SE-HPLC___HMMS">0.3</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1___2___&lt;=B9___Essentially free from visible particulates___97___0.2___0.6-----SE-HPLC___MONOMER">99.6</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1___2___&lt;=B9___Essentially free from visible particulates___97___0.2___0.6-----STERILITY___STERILITY">NR</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1___2___&lt;=B9___Essentially free from visible particulates___97___0.2___0.6-----SUBVISIBLE PARTICLES___SUBVISIBLE PARTICLES">NR</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1___2___&lt;=B9___Essentially free from visible particulates___97___0.2___0.6-----SUBVISIBLE PARTICLES___SUBVISIBLE PARTICLES &gt;= 10M">NR</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1___2___&lt;=B9___Essentially free from visible particulates___97___0.2___0.6-----SUBVISIBLE PARTICLES___SUBVISIBLE PARTICLES &gt;= 25M">NR</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1___2___&lt;=B9___Essentially free from visible particulates___97___0.2___0.6-----UV SPECTROSCOPY___PROTEIN CONCENTRATION">2.0</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1___2___&lt;=B9___Essentially free from visible particulates___97___0.2___0.6-----ICE___ACIDIC SPECIES">40.4</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1___2___&lt;=B9___Essentially free from visible particulates___97___0.2___0.6-----ICE___BASIC SPECIES">14.7</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1___2___&lt;=B9___Essentially free from visible particulates___97___0.2___0.6-----ICE___MAIN SPECIES">44.9</td>
      <td id="id68-----39-----BCMA;17-001511;-20C;INVERTED1-----1___2___&lt;=B9___Essentially free from visible particulates___97___0.2___0.6-----PH___PH">5.8</td>
    </tr>
  </table>
</tablegroup>